Filgotinib to Treat Acute Severe Refractory Ulcerative Colitis: A Case Report and Review of the Literature
Filgotinib may be an effective second-line therapy in an emergency setting such as ASUC in patients unresponsive to conventional therapy.
Authors
- Giuseppe Vitiello (ORCID: https://orcid.org/0000-0002-5710-7904)
- Roberta Abete (ORCID: https://orcid.org/0000-0001-8770-7946)
- Pasquale Madonna (ORCID: https://orcid.org/0000-0003-3637-3055)
- Franco Scaldaferri (ORCID: https://orcid.org/0000-0001-8334-7541)
- Leonardo De Luca (ORCID: https://orcid.org/0000-0002-8552-1272)
- Silvia Sedda
- Marina Lugarà
- M Maione (ORCID: https://orcid.org/0000-0003-0057-9094)
- Giuliana Vespere (ORCID: https://orcid.org/0009-0007-1249-0309)
- Alfredo D’Avino
- Antonietta Tazza
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Ospedale D. Cotugno (IT)
- Ospedale Civile di Venezia (IT)
Publication Details
- Journal
- Case Reports in Gastroenterology
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1159/000545263
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63